Question

Describe the collaboration of 1 faith based organization or mission with a health national organization or bilateral organization or a private foundation to address the concern of child health or immunization in a low or middle income country , focus on three major points

Answer 1

Vaccination is among the greatest public health achievements of the 20^th century, banishing feared diseases from the lives of those fortunate enough to be immunized. But 1.5 million people continue to die each year from vaccine-preventable diseases.

The Global Vaccine Action Plan (GVAP) is a framework adopted by all the World Health Organization (WHO) Member States at the Sixty-fifth World Health Assembly in May 2012 to achieve the vision of the Decade of Vaccines (DoV) 2011–2020 of “a world in which all individuals and communities enjoy lives free from vaccine-preventable diseases”. The GVAP’s mission is to “improve health by extending by 2020 and beyond the full benefits of immunization to all people, regardless of where they are born, who they are, or where they live”.

The Global Vaccine Action Plan (GVAP) is a framework to end that inequity and extend the benefits of vaccination to everyone, regardless of where they are born.

The plan received support from stakeholders involved in immunization, including governments and elected officials, health professionals, academia, manufacturers, global agencies, development partners, civil society, media, and the private sector.

They have initiated a report on the situation of middle-income countries with regard to immunization and independent voluntary submissions from various partners on the activities they conducted under the GVAP umbrella.

The Sabin Vaccine Institute’s Access and Uptake programs support GVAP at the country level through several pathways:

Sabin’s Sustainable Immunization Financing program works with lower- and lower-middle income countries to establish sustainable, predictable financing of their immunization programs. A goal which corresponds to country ownership. Countries achieve sustainable immunization financing by developing new domestic funding sources, implementing budget line items for immunization, improving immunization budget management and enacting new laws assuring public funding for immunization programs. Sabin documents and disseminates data on countries’ progress in prioritizing immunization and establishing predictable funding for their programs. Sabin also organizes high-level GVAP briefings in partner countries and encourages immunization managers to integrate GVAP objectives into annual program work plans.

Sabin is working to prevent typhoid and other invasive salmonelloses through research, education, and advocacy. Sabin is leading a large, landmark surveillance study to establish the burden of typhoid and paratyphoid in Bangladesh, India, Nepal, and Pakistan. Data from the project will inform implementation of the new typhoid conjugate vaccine, as well as policy recommendations for typhoid and paratyphoid prevention and control.

In 2017, Sabin’s Coalition against Typhoid joined forces with the Typhoid Vaccine Acceleration Consortium (TyVAC) to focus attention on integrated solutions, including typhoid conjugate vaccines and water, sanitation, and hygiene improvements, to reduce the burden and impact of typhoid. Sabin is also addressing global policy by providing evidence for the use of licensed typhoid conjugate vaccines, which have been recommended for use by SAGE.